Detailed Information

Cited 19 time in webofscience Cited 20 time in scopus
Metadata Downloads

G alpha 13 ablation reprograms myofibers to oxidative phenotype and enhances whole-body metabolism

Full metadata record
DC Field Value Language
dc.contributor.authorKoo, Ja Hyun-
dc.contributor.authorKim, Tae Hyun-
dc.contributor.authorPark, Shi-Young-
dc.contributor.authorJoo, Min Sung-
dc.contributor.authorHan, Chang Yeob-
dc.contributor.authorChoi, Cheol Soo-
dc.contributor.authorKim, Sang Geon-
dc.date.available2020-02-27T16:44:10Z-
dc.date.created2020-02-06-
dc.date.issued2017-10-02-
dc.identifier.issn0021-9738-
dc.identifier.urihttps://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/5591-
dc.description.abstractSkeletal muscle is a key organ in energy homeostasis owing to its high requirement for nutrients. Heterotrimeric G proteins converge signals from cell-surface receptors to potentiate or blunt responses against environmental changes. Here, we show that muscle-specific ablation of G alpha 13 in mice promotes reprogramming of myofibers to the oxidative type, with resultant increases in mitochondrial biogenesis and cellular respiration. Mechanistically, G alpha 13 and its downstream effector RhoA suppressed nuclear factor of activated T cells 1 (NFATc1), a chief regulator of myofiber conversion, by increasing Rho-associated kinase 2-mediated (Rock2-mediated) phosphorylation at Ser243. Ser243 phosphorylation of NFATc1 was reduced after exercise, but was higher in obese animals. Consequently, G alpha 13 ablation in muscles enhanced whole-body energy metabolism and increased insulin sensitivity, thus affording protection from diet-induced obesity and hepatic steatosis. Our results define G alpha 13 as a switch regulator of myofiber reprogramming, implying that modulations of G alpha 13 and its downstream effectors in skeletal muscle are a potential therapeutic approach to treating metabolic diseases.-
dc.language영어-
dc.language.isoen-
dc.publisherAMER SOC CLINICAL INVESTIGATION INC-
dc.relation.isPartOfJOURNAL OF CLINICAL INVESTIGATION-
dc.subjectMUSCLE-FIBER-TYPE-
dc.subjectINSULIN-RESISTANCE-
dc.subjectMITOCHONDRIAL-FUNCTION-
dc.subjectNUCLEAR FACTOR-
dc.subjectLIPID-CONTENT-
dc.subjectEXERCISE-
dc.subjectEXPRESSION-
dc.subjectCELLS-
dc.subjectMICE-
dc.subjectPGC-1-ALPHA-
dc.titleG alpha 13 ablation reprograms myofibers to oxidative phenotype and enhances whole-body metabolism-
dc.typeArticle-
dc.type.rimsART-
dc.description.journalClass1-
dc.identifier.wosid000412017800029-
dc.identifier.doi10.1172/JCI92067-
dc.identifier.bibliographicCitationJOURNAL OF CLINICAL INVESTIGATION, v.127, no.10, pp.3845 - 3860-
dc.identifier.scopusid2-s2.0-85030562828-
dc.citation.endPage3860-
dc.citation.startPage3845-
dc.citation.titleJOURNAL OF CLINICAL INVESTIGATION-
dc.citation.volume127-
dc.citation.number10-
dc.contributor.affiliatedAuthorChoi, Cheol Soo-
dc.type.docTypeArticle-
dc.subject.keywordPlusMUSCLE-FIBER-TYPE-
dc.subject.keywordPlusINSULIN-RESISTANCE-
dc.subject.keywordPlusMITOCHONDRIAL-FUNCTION-
dc.subject.keywordPlusNUCLEAR FACTOR-
dc.subject.keywordPlusLIPID-CONTENT-
dc.subject.keywordPlusEXERCISE-
dc.subject.keywordPlusEXPRESSION-
dc.subject.keywordPlusCELLS-
dc.subject.keywordPlusMICE-
dc.subject.keywordPlusPGC-1-ALPHA-
dc.relation.journalResearchAreaResearch & Experimental Medicine-
dc.relation.journalWebOfScienceCategoryMedicine, Research & Experimental-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
Files in This Item
There are no files associated with this item.
Appears in
Collections
의과대학 > 의예과 > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Choi, Cheol Soo photo

Choi, Cheol Soo
College of Medicine (Premedical Course)
Read more

Altmetrics

Total Views & Downloads

BROWSE